from the ovaries of these animals (Arthur & Boyd, 1974) . Cholesterol, cytochrome P-450 and cholesterol side-chain-cleavage activity were measured in the mitochondria as described previously (Arthur & Boyd, 1974) . The results of such an experiment are shown in Fig Rats were injected with luteinizing hormone (20pglrat) or 0.9% NaCl 1 h beforc they were killed. Cholesterol side-chain-cleavage activity was measured in the luteal rnitochondria of these rats, as described previously (Arthur & Boyd, 1974) . Mitochondria from luteinizing-hornmone-treated animals incubated with (A) and without (A) added ( 2 6 0~~) cholesterol. Mitochondria from control animals incubated with ( 0 ) and without (0) added (260 ~U M ) cholesterol.
Vol. 3 Table 1 . Eflect of luteiriizing-hormone injection of rats on cholesterol content, cytochrome
P-450 content and pregnenolone production in Iirteal mitochondria
Luteal mitochondria were isolated from ovaries of superovulated rats which had previously been treated with luteinizing hormone or 0.9% NaCI 1 h before being killed. Mitochondrial cholesterol, pregnenolone production and cytochrome P-450 were measured as described previously (Arthur & Boyd, 1974 (1975) who found that treatment of superovulated rats for 1 h with luteinizing hormone stimulated the percentage conversion of tracer [4-I4C]-cholesterol into 4-14C-labelled steroid products in subsequently isolated luteal mitochondria. This apparent discrepancy can be explained, however, by the decrease in total cholesterol pool size in luteal mitochondria from luteinizing-hormone-treated rats compared with luteal mitochondria from rats treated with NaCl ( Table 1) . The total pregnenolone production in the luteal mitochondria from luteinizing-hormone-treated rats was also decreased ( (Table 1) . Total cytochrome P-450 in the mitochondria was unchanged by the luteinizing-hormone treatment ( Table 1) . The apparent decrease in cholesterol side-chain-cleavage activity on luteinizinghormone treatment is difficult to explain in view of the reported stimulation of steroidogenesis caused by luteinizing hormone (see references above). However, if exogenous cholesterol is added to incubations the mitochondria from luteinizing-hormone-treated rats are now capable of producing more pregnenolone than those from control animals (Fig. 1) . Luteinizing-hormone treatment of rats in vivo causes an activation of the cholesterol side-chain-cleavage enzymes in isolated luteal mitochondria, which is only observable on provision of the mitochondria with adequate supplies of exogenous cholesterol. Thus in vivo after luteinizing-hormone treatment there could be an increased turnover of cholesterol in the luteal mitochondria causing an increase in luteal-progesterone output. When mitochondria are isolated they are cut off from a supply of cholesterol and unless this sterol is added to the organelles they appear to be less active than mitochondria from control animals. This work emphasizes that the supply of cholesterol to the mitochondria1 cholesterol side-chain-cleavage enzymes may be important in controlling the rate of steroidogenesis in the rat corpus luteum (Hermier et a/ 49, [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] It has been shown (Gutte, 1975 ) that a synthetic 70-residue analogue of RNAase A (ribonuclease A) lacking (a) the N-terminal portion including histidine-12, (b) several superficial loops distant from the active site, and (c) all four disulphide bridges of the native enzyme, retained considerable activity against R N A and was indistinguishable from the parent molecule with respect to substrate specificity in the transphosphorylation step.
The new 63-residue analogue (Table 1) was prepared in order to demonstrate that polypeptides of that size can be synthesized by the solid-phase method (Merrifield, 1969) with reproducible results. Two of the four disulphide bonds present in native RNAase A were incorporated in the synthetic 63-residue analogue, thus increasing its conformational stability.
The 63-residue polypeptide chain was assembled on the resin by procedures described previously (Gutte, 1975) . The concentration of trifluoroacetic acid during the deprotection steps, however, was raised from 20 t o 30% (v/v) in CHzClz to achieve complete removal of the N-terminal Boc groups (R. E. Reid, personal communication). The side chains of cysteine, lysine, and tyrosine were protected by the 4-methoxybenzyl, 2-chlorobenzyloxycarbonyl and 2,6-dichlorobenzyl group respectively. After completion of the synthesis, the 63-residue analogue was deprotected and cleaved from the resin by anhydrous HF in the presence of anisole. Then HF and anisole were evaporated and the synthetic product was extracted from the resin with trifluoroacetic acid. The solvent was removed in a rotary evaporator and the oily residue was treated with O.OSM-NH~HCO~, adjusted to p H 8. The resulting suspension was stirred overnight, then saturated with urea, and centrifuged. During dialysis of the solution another precipitate formed, the amount of which increased with decreasing urea concentration in the dialysis sac. It was centrifuged and the supernatant was freeze-dried. The material obtained by freezedrying was used for all further experiments. First it was reduced with mercaptoethanol (100-fold molar excess per half-cystine residue) in 5~-u r e a at pH3.65. Then excess of 
